Abstract:Microglia as an important type of innate immune cell in the brain have been considered as an effective therapeutic target for the treatment of central nervous degenerative diseases. Herein, we report cell membrane coated novel biomimetic Cu<sub>2–<i>x</i></sub>Se-PVP-Qe nanoparticles (denoted as nanoparticles, where PVP is poly(vinylpyrrolidone), Qe is quercetin, and CM is the cell membrane of neuron cells) for effectively targeting and modulating microglia to treat Parkinson's disease (PD). The CSPQ nanoparticles exhibit multienzyme activities and could effectively scavenge the reactive oxygen species and promote the polarization of microglia into the anti-inflammatory M2-like phenotype to relieve neuroinflammation. We reveal that biomimetic nanoparticles targeted microglia through the specific interactions between the membrane surface vascular cells adhering to molecule-1 and α4β1 integrin expressed by microglia. They could significantly improve the symptoms of PD mice to result in an excellent therapeutic efficacy, as evidenced by the recovery of their dopamine level in cerebrospinal fluid, tyrosine hydroxylase, and ionized calcium binding adapter protein 1 to normal levels. Our work demonstrates the great potential of these robust biomimetic nanoparticles in the targeted treatment of PD and other central nervous degenerative diseases.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/jacs.0c09390?goto=supporting-info">https://pubs.acs.org/doi/10.1021/jacs.0c09390</a>.Additional information including materials, synthesis, and characterization assay of enzymatic activity and ROS scavenging capacity of QP complex, CSP, and CSPQ nanoparticles (TEM, particle size distribution, TGA, ESR, reaction mechanism of enzyme activity detection; ζ potential; CLSM images and FCAS of intracellular ROS level); immunofluorescence staining of β1 integrins in BV2 cells; PA images and signals intensities of the brain after intravenous injection with nanoparticles; photograph of brain slice stained with rubeanic acid; H&E images of major organs (<a class="ext-link" href="/doi/suppl/10.1021/jacs.0c09390/suppl_file/ja0c09390_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Focused ultrasound-mediated cerium-based nanoreactor against Parkinson's disease via ROS regulation and microglia polarization

A Dual Synergetic Nanoreactor for Managing Parkinson's Disease by Regulating Inflammation and Mitigating Oxidative Damage

An upconversion nanoplatform based multi-effective theatment for Parkinson’s disease

Near-Infrared Radiation-Assisted Drug Delivery Nanoplatform to Realize Blood–Brain Barrier Crossing and Protection for Parkinsonian Therapy

An Upconversion Nanoplatform Based Multi-Effective Theatment for Parkinson's Disease

Ultrasmall Coordination Polymers for Alleviating ROS-Mediated Inflammatory and Realizing Neuroprotection Against Parkinson’s Disease

Targeting Microglia for Therapy of Parkinson’s Disease by Using Biomimetic Ultrasmall Nanoparticles

Chiral metal-organic frameworks incorporating nanozymes as neuroinflammation inhibitors for managing Parkinson’s disease

Chiral metal-organic frameworks incorporating nanozymes as neuroinflammation inhibitors for managing Parkinson's disease

Biomimetic Biomembrane Encapsulation and Targeted Delivery of a Nitric Oxide Release Platform for Therapy of Parkinson's Disease.

Localized Delivery of Curcumin-Loaded Nanoparticles to the Brain for Treatment of Parkinson'S Disease Using Focused Ultrasound

Catalytic-Enhanced Lactoferrin-Functionalized Au-Bi2 Se3 Nanodots for Parkinson's Disease Therapy Via Reactive Oxygen Attenuation and Mitochondrial Protection.

Near-infrared Enhanced Organic Se-Doped Carbon Nitride Quantum Dots Nanozymes As SOD/CAT Mimics for Anti-Parkinson Via ROS-NF-κB-NLRP3 Inflammasome Axis

Nir-Ii-Activated Yolk-Shell Nanostructures As An Intelligent Platform For Parkinsonian Therapy

Brain-targeted Gene Delivery of ZnO Quantum Dots Nanoplatform for the Treatment of Parkinson Disease

Engineered Inhalable Nanocatalytic Therapeutics for Parkinson's Disease by Inducing Mitochondrial Autophagy

Improving treatment for Parkinson's disease: Harnessing photothermal and phagocytosis-driven delivery of levodopa nanocarriers across the blood-brain barrier

Iron ions-sequestrable and antioxidative carbon dot-based nano-formulation with nitric oxide release for Parkinson's disease treatment

Nano-particle Mediated Inhibition of Parkinson’s Disease Using Computational Biology Approach

Parkinson Disease -Targeted Nanocapsules for Synergistic Treatment: Combining Dopamine Replacement and Neuroinflammation Mitigation

Treatment of Parkinson's Disease in Rats by Nrf2 Transfection Using MRI-guided Focused Ultrasound Delivery of Nanomicrobubbles